These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 9362539)

  • 21. High activity of N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and cytolytic perforin in cloned cell lines is not demonstrable in in-vivo-induced cytotoxic effector cells.
    Dennert G; Anderson CG; Prochazka G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5004-8. PubMed ID: 2955414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis.
    Zhang D; Beresford PJ; Greenberg AH; Lieberman J
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5746-51. PubMed ID: 11331782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell death mediated by alloreactive cytotoxic T cells via the granule exocytosis or the Fas pathway is independent of p34cdc2 kinase: Fas dependent killing of cells arrested in the cell cycle.
    Waring P; Müllbacher A
    Immunol Cell Biol; 2001 Jun; 79(3):264-73. PubMed ID: 11380680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G; Balkow S; Schimmer S; Schepers K; Simon MM; Dittmer U
    Virology; 2004 Dec; 330(2):365-74. PubMed ID: 15567431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a granule-independent lytic mechanism used by CTL hybridomas.
    Garner R; Helgason CD; Atkinson EA; Pinkoski MJ; Ostergaard HL; Sorensen O; Fu A; Lapchak PH; Rabinovitch A; McElhaney JE
    J Immunol; 1994 Dec; 153(12):5413-21. PubMed ID: 7527440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin.
    Nakajima H; Park HL; Henkart PA
    J Exp Med; 1995 Mar; 181(3):1037-46. PubMed ID: 7869027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothesis: cytotoxic lymphocyte granule serine proteases activate target cell endonucleases to trigger apoptosis.
    Smyth MJ; Browne KA; Thia KY; Apostolidis VA; Kershaw MH; Trapani JA
    Clin Exp Pharmacol Physiol; 1994 Jan; 21(1):67-70. PubMed ID: 8156655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting edge: rapid and efficient in vivo cytotoxicity by cytotoxic T cells is independent of granzymes A and B.
    Regner M; Pavlinovic L; Koskinen A; Young N; Trapani JA; Müllbacher A
    J Immunol; 2009 Jul; 183(1):37-40. PubMed ID: 19525394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability.
    Bochan MR; Goebel WS; Brahmi Z
    Cell Immunol; 1995 Sep; 164(2):234-9. PubMed ID: 7656332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B.
    Trapani JA
    Aust N Z J Med; 1995 Dec; 25(6):793-9. PubMed ID: 8770355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
    Berke G; Rosen D; Ronen D
    Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
    Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
    J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line.
    Montel AH; Bochan MR; Goebel WS; Brahmi Z
    Cell Immunol; 1995 Oct; 165(2):312-7. PubMed ID: 7553897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA; Ward B; Schatzle JD; Bennett M
    Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perforin and the granule exocytosis cytotoxicity pathway.
    Catalfamo M; Henkart PA
    Curr Opin Immunol; 2003 Oct; 15(5):522-7. PubMed ID: 14499260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors.
    Kam CM; Hudig D; Powers JC
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):307-23. PubMed ID: 10708866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells.
    Renner C; Held G; Ohnesorge S; Bauer S; Gerlach K; Pfitzenmeier JP; Pfreundschuh M
    Cancer Immunol Immunother; 1997 Apr; 44(2):70-6. PubMed ID: 9177467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.